Related Experiment Video
Updated: May 19, 2026

08:46
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
Published on: March 7, 2017
Diffuse brainstem glioma: prognostic factors
Marcos Dellaretti1, Nicolas Reyns, Gustavo Touzet
1Department of Neurosurgery, CHRU Hôpital Roger Salengro, Lille, France. mdellaretti@mac.com
Journal of Neurosurgery
|September 4, 2012
Summary
Histological grade is the key prognostic factor for brainstem glioma survival. While MRI findings also show differences, only tumor grade significantly impacts patient outcomes in multivariate analysis.
Area of Science:
- Neuro-oncology
- Radiology
- Pathology
Background:
- Brainstem gliomas were historically viewed as a uniform entity.
- Advances in MRI revealed heterogeneity within brainstem gliomas.
- Certain subgroups exhibit improved long-term survival prognoses.
Purpose of the Study:
- To retrospectively analyze prognostic factors in histopathologically confirmed brainstem gliomas.
- To assess the significance of histological grade, patient age, and MRI findings on survival.
- To identify key predictors of long-term outcomes in brainstem glioma patients.
Main Methods:
- Evaluation of 100 patients with brainstem glioma (63 adults, 37 children).
- Histopathological diagnosis and grading of gliomas.
- Analysis of MRI findings, including contrast enhancement patterns.
- Kaplan-Meier survival analysis and Cox proportional hazards regression.
Main Results:
- Mean survival: 57 months for low-grade vs. 13.8 months for high-grade gliomas (p < 0.001).
- Mean survival: 54.2 months for non-enhancing vs. 21.7 months for enhancing lesions (p < 0.001).
- Multivariate analysis identified histological grade as the sole significant prognostic factor (p < 0.001).
Conclusions:
- Histological grade and MRI features are significant prognostic indicators for brainstem glioma survival.
- In multivariate analysis, only histological grade proved to be a significant predictor of patient survival.
- This highlights the critical role of tumor grading in determining prognosis for brainstem gliomas.

